CA Stock MarketDetailed Quotes
BIOV BioVaxys Technology Corp
- 0.065
- 0.0000.00%
15min DelayMarket Closed Dec 27 15:52 ET
17.03MMarket Cap-2.17P/E (TTM)
0.070High0.060Low559.39KVolume0.060Open0.065Pre Close35.68KTurnover0.10052wk High0.22%Turnover Ratio262.06MShares0.03552wk Low-0.03EPS TTM16.34MFloat Cap0.780Historical HighLossP/E (Static)251.42MShs Float0.010Historical Low-0.06EPS LYR15.39%Amplitude--Dividend TTM-65.00P/B1Lot Size--Div YieldTTM
BioVaxys Technology Corp Key Stats
Quarterly+Annual
YOY
| (Q3)Jul 31, 2024 | (Q2)Apr 30, 2024 | (Q1)Jan 31, 2024 | (FY)Oct 31, 2023 | (Q4)Oct 31, 2023 | (Q3)Jul 31, 2023 | (Q2)Apr 30, 2023 | (Q1)Jan 31, 2023 | (FY)Oct 31, 2022 | (Q4)Oct 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | -1,636.08%-412.2K | 38.62%-436.93K | 100.75%2.38K | 33.01%-1.05M | 99.03%-2.02K | 68.67%-23.74K | 15.69%-711.83K | 28.79%-317.25K | 70.26%-1.57M | 72.51%-209.02K |
| Net income from continuing operations | 58.00%-1.19M | 63.58%-542.39K | 154.19%518.05K | 34.45%-7.69M | 71.72%-2.42M | -209.69%-2.82M | -40.84%-1.49M | 21.07%-956.05K | -81.60%-11.73M | -239.19%-8.55M |
| Operating gains losses | 3,842.92%1.28M | ---- | ---- | -192.68%-229.95K | ---171.2K | ---34.3K | -271.54%-36.03K | 117.34%11.57K | 4,282.02%248.11K | ---- |
| Asset impairment expenditure | --0 | ---- | ---- | -80.46%1.45M | -80.46%1.45M | ---947.46K | ---- | ---- | --7.4M | --7.4M |
| Remuneration paid in stock | -79.38%9.01K | -74.69%11.78K | -65.40%22.46K | -69.87%150.63K | -102.69%-4.52K | -45.25%43.71K | -47.41%46.53K | -60.33%64.91K | -56.04%499.97K | -46.90%168.01K |
| Other non cashItems | ---- | ---- | -12,767.42%-880.39K | 2,852.78%3.08M | -158.65%-15.26K | 11,580.21%3.06M | 65.49%26.8K | -80.60%6.95K | 0.27%104.23K | 8.67%26.03K |
| Change In working capital | -176.24%-518.49K | 145.57%94.52K | -38.37%342.26K | 14.99%2.19M | 132.81%1.16M | -6.32%680.08K | -275.70%-207.43K | -1.00%555.37K | 2,383.94%1.9M | -64.72%498.69K |
| -Change in receivables | -423.34%-37.23K | -533.98%-39.05K | 64.70%-12.72K | -1,250.79%-42.23K | -1.62%-8.08K | -200.61%-7.11K | 240.22%9K | -428.45%-36.04K | 668.99%3.67K | -777.51%-7.95K |
| -Change in prepaid assets | -137.34%-75.83K | 244.29%130.48K | 56.22%-189.22K | 42.53%-121.47K | 181.52%198.1K | 465.66%203.1K | -617.30%-90.43K | -5,273.45%-432.24K | -147.79%-211.36K | -118.27%-243.02K |
| -Change in payables and accrued expense | -183.75%-405.44K | 102.46%3.1K | -46.84%544.2K | 11.43%2.35M | 29.53%971.01K | -29.12%484.09K | -191.91%-126K | 88.99%1.02M | 502.21%2.11M | 811.51%749.66K |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | -1,636.08%-412.2K | 38.62%-436.93K | 100.75%2.38K | 33.01%-1.05M | 99.03%-2.02K | 68.67%-23.74K | 15.69%-711.83K | 28.79%-317.25K | 70.26%-1.57M | 72.51%-209.02K |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | -1 | 0 | ||||||||
| Net intangibles purchas and sale | ---1 | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | ---1 | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | 743.4K | 2.68%687.94K | 289.59%962.67K | -17.25%917.1K | 0 | 0 | -14.06%670K | 247.1K | -67.77%1.11M | -45.85%328.6K |
| Net issuance payments of debt | --13.83K | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Net common stock issuance | --729.57K | 7.67%721.37K | 289.59%962.67K | -17.25%917.1K | --0 | --0 | -14.06%670K | --247.1K | -63.79%1.11M | -32.11%328.6K |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | --743.4K | 2.68%687.94K | 289.59%962.67K | -17.25%917.1K | --0 | --0 | -14.06%670K | --247.1K | -67.77%1.11M | -45.85%328.6K |
| Net cash flow | ||||||||||
| Beginning cash position | 460.92%159.74K | 1,247.71%965.14K | -99.31%977 | -76.08%141.9K | -98.92%423 | -74.92%28.48K | -51.94%71.61K | -76.08%141.9K | -75.52%593.12K | -94.73%39.05K |
| Current changes in cash | 1,494.94%331.2K | -1,825.12%-805.35K | 1,475.68%965.05K | 70.46%-137.75K | -101.69%-2.02K | 68.67%-23.74K | 35.30%-41.83K | 84.25%-70.15K | 74.87%-466.36K | 177.93%119.58K |
| Effect of exchange rate changes | 97.80%-95 | 96.77%-42 | -565.67%-892 | -120.95%-3.17K | 115.38%2.57K | -439.80%-4.31K | -104.45%-1.3K | -109.75%-134 | -40.51%15.15K | -385.16%-16.73K |
| End cash Position | 115,939.01%490.85K | 460.92%159.74K | 1,247.71%965.14K | -99.31%977 | -99.31%977 | -98.92%423 | -74.92%28.48K | -51.94%71.61K | -76.08%141.9K | -76.08%141.9K |
| Free cash from | -1,636.09%-412.2K | -109.78%-1.49M | 100.75%2.38K | 33.01%-1.05M | 99.03%-2.02K | 68.67%-23.74K | 15.69%-711.83K | 28.79%-317.25K | 70.26%-1.57M | 72.51%-209.02K |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Heat List
CA
Overall
Symbol
Price
% Chg
No Data